|Articles|September 23, 2010

Whey Protein Shows Significant Improvement on Blood Pressure

Whey protein may have an influence on lowering blood pressure, according to research published in the upcoming November issue of International Dairy Journal.In a six-week controlled intervention, researchers at Washington State University tested the effects of daily consumption of 28 g of hydrolyzed or non-hydrolyzed whey protein beverages on young men and women.

Whey protein may have an influence on lowering blood pressure, according to research published in the upcoming November issue of International Dairy Journal.

In a six-week controlled intervention, researchers at Washington State University tested the effects of daily consumption of 28 g of hydrolyzed or non-hydrolyzed whey protein beverages on young men and women.

Systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial blood pressure (MAP) were measured.

Comparing hydrolyzed to non-hydrolyzed whey, no differences on influencing the above measures were noted; but the influence of both wheys on blood pressure markers was often significant. In subjects with elevated SBP and DBP, whey significantly decreased these measures. In subjects with high SBP only, whey significantly decreased this measure. For subjects with healthy blood pressure levels, SBP, DBP, and MAP remained unchanged after baseline.

Total and low-density lipoprotein (LDL or 'bad' cholesterol) was also lowered in subjects after whey consumption.

The results of this intervention left researchers to conclude that 'Whey protein beverages may be useful for the dietary treatment of prehypertension and/or stage 1 hypertension.'

To read the study abstract, click here.


Related to this article

SupplySide Global Vitaquest
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Michael Anthonavage, VP of innovation at Vitaquest International, about the company’s 2027 consumer trends forecast and how it’s shaping supplement formulation.
Laurentia Bliss
Live from SupplySide Global 2026, Laurentia Bliss talks about new athlete-focused research on Magtein, ThreoTech’s brain-targeted magnesium ingredient, and upcoming innovations like effervescent tablets and gummies.
Klaus Neumann
Live from SupplySide Global 2026, Klaus Neumann talks about Concordix's chewable supplement line spanning beauty and gut-immune health, including BeautyBioti, a Skin & Hair Vitality Complex, and FortiBiotic.